Compare ACADIA Pharmaceuticals Inc. (ACAD) vs Allbirds Inc (BIRD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ACADIA Pharmaceuticals Inc. vs Allbirds Inc — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.45 (market cap $5.07B), while Allbirds Inc trades at $2.6 (market cap $30.00M). The key difference: ACADIA Pharmaceuticals Inc. is far larger — about 169× Allbirds Inc's market cap, and ACADIA Pharmaceuticals Inc. is trading nearer its 52-week high, Allbirds Inc nearer its low. Which is the better fit depends on your goals.
| ACAD | BIRD | |
|---|---|---|
Market Cap | $5.07B | $30.00M |
Sector | Health | Consumer Cyclical |
52-Week High | $29.41 | $16.99 |
52-Week Low | $20.06 | $2.21 |
Enterprise Value | $4.19B | $48.86M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →About Allbirds Inc
Allbirds Inc is a global lifestyle brand that innovates with naturally derived materials to make footwear and apparel products. Its primary source of revenue is from sales of shoes and apparel products in its directly owned digital and physical retail channels.
Read more on BIRD →
